Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe.
Cainzos-Achirica M, Varas-Lorenzo C, Pottegård A, Asmar J, Plana E, Rasmussen L, Bizouard G, Forns J, Hellfritzsch M, Zint K, Perez-Gutthann S, Pladevall-Vila M. Cainzos-Achirica M, et al. Among authors: zint k. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):713-723. doi: 10.1002/pds.4416. Epub 2018 Mar 23. Pharmacoepidemiol Drug Saf. 2018. PMID: 29570897
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
Paquette M, Riou França L, Teutsch C, Diener HC, Lu S, Dubner SJ, Ma CS, Rothman KJ, Zint K, Halperin JL, Huisman MV, Lip GYH, Nieuwlaat R. Paquette M, et al. Among authors: zint k. J Am Coll Cardiol. 2017 Sep 26;70(13):1573-1583. doi: 10.1016/j.jacc.2017.07.793. J Am Coll Cardiol. 2017. PMID: 28935034 Free article.
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Lu S, Bartels DB, Lip GYH; GLORIA-AF Investigators. Huisman MV, et al. Among authors: zint k. Am Heart J. 2018 Apr;198:55-63. doi: 10.1016/j.ahj.2017.08.018. Epub 2017 Aug 31. Am Heart J. 2018. PMID: 29653649
Evaluating utilization patterns of oral anticoagulants in routine care.
Gopalakrishnan C, Schneeweiss S, Bartels DB, Zint K, Santiago Ortiz A, Huybrechts KF. Gopalakrishnan C, et al. Among authors: zint k. J Thromb Haemost. 2019 Jul;17(7):1033-1043. doi: 10.1111/jth.14467. Epub 2019 May 29. J Thromb Haemost. 2019. PMID: 31038824 Free article.
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.
Paquette M, França LR, Teutsch C, Diener HC, Lu S, Dubner SJ, Ma CS, Rothman KJ, Zint K, Halperin JL, Olshansky B, Huisman MV, Lip GYH, Nieuwlaat R. Paquette M, et al. Among authors: zint k. Am J Cardiol. 2020 Feb 1;125(3):383-391. doi: 10.1016/j.amjcard.2019.10.047. Epub 2019 Nov 7. Am J Cardiol. 2020. PMID: 31785775 Free article. Clinical Trial.
29 results